Sign In
Buy MCK
$763.91
+18.79 (+2.52%)
At Close: Jun 23, 2026
Here's Why You Should Hold on to OPKO Health (OPK) Stock For Now
03:50pm, Thursday, 21'st Jul 2022 Zacks Investment Research
Investors continue to be optimistic about OPKO Health (OPK) owing to its potential in Rayaldee and a few strategic agreements.
Potbelly's and Rio Tinto have been highlighted as Zacks Bull and Bear of the Day
11:45am, Thursday, 21'st Jul 2022 Zacks Investment Research
Potbelly's and Rio Tinto have been highlighted as Zacks Bull and Bear of the Day.
Should You Invest in the First Trust Consumer Staples AlphaDEX ETF (FXG)?
10:20am, Thursday, 21'st Jul 2022 Zacks Investment Research
Sector ETF report for FXG
Ron Muhlenkamp's Firm Goes on Selling Spree in 2nd Quarter
03:39pm, Wednesday, 20'th Jul 2022
Muhlenkamp & Co. Inc., the investment firm founded by Ronald Muhlenkamp (Trades, Portfolio) in 1977, released its equity portfolio for the second quarter earlier this week.
QIAGEN (QGEN) QCI's Robust Adoption to Enhance Patient Outcome
02:50pm, Wednesday, 20'th Jul 2022 Zacks Investment Research
QIAGEN's (QGEN) QCI platform is expected to significantly streamline NGS data analysis and variant interpretation, and enable swift and confident shift by users from raw NGS data to clinical report.
3 Medical Device Stocks With Potential to Fight Recession Risk
01:19pm, Wednesday, 20'th Jul 2022 Zacks Investment Research
The decline in U.S. GDP during the first quarter and 26% decline in the S&P 500 Index so far this year fuel the risk of a recession. MCK, PDCO & AMN have the potential to help investors ward off volat
3 Medical Device Stocks With Potential to Fight Recession Risk
10:54am, Wednesday, 20'th Jul 2022
The decline in U.S. GDP during the first quarter and 26% decline in the S&P 500 Index so far this year fuel the risk of a recession. MCK, PDCO & AMN have the potential to help investors ward off volat
NextGen (NXGN)-InstaMed Ink Deal to Improve Payment Processing
03:47pm, Tuesday, 19'th Jul 2022 Zacks Investment Research
NextGen's (NXGN) latest expanded deal with InstaMed is expected to significantly simplify payment methods for both patients and providers.
3 Reasons to Retain DaVita (DVA) Stock in Your Portfolio
03:35pm, Tuesday, 19'th Jul 2022 Zacks Investment Research
Investors remain optimistic about DaVita (DVA) due to strength in its DaVita Kidney Care.
Reasons to Retain Surmodics (SRDX) Stock in Your Portfolio
03:34pm, Monday, 18'th Jul 2022 Zacks Investment Research
Investors continue to be optimistic about Surmodics (SRDX) owing to its solid prospects in the thrombectomy business.
Alcon's (ALC) Product Launches, Market Recovery Aid Growth
02:40pm, Monday, 18'th Jul 2022 Zacks Investment Research
Despite bearing the brunt of inflationary pressure across both Total Surgical and Vision Care franchises, Alcon (ALC) succeeds in mitigating much of the impact through cost-improvement efforts.
McKesson (MCK) Gains But Lags Market: What You Should Know
10:00pm, Friday, 15'th Jul 2022 Zacks Investment Research
McKesson (MCK) closed at $330 in the latest trading session, marking a +1.08% move from the prior day.
3 Reasons Why BD (BDX) is a Great Pick For Your Portfolio Now
03:36pm, Friday, 15'th Jul 2022 Zacks Investment Research
Investors continue to be optimistic about BD (BDX) owing to a few regulatory approvals and strategic deals.
Has McKesson (MCK) Outpaced Other Medical Stocks This Year?
01:40pm, Friday, 15'th Jul 2022 Zacks Investment Research
Here is how McKesson (MCK) and Immunocore Holdings PLC Sponsored ADR (IMCR) have performed compared to their sector so far this year.
Zacks Value Trader Highlights: H&R Block, McKesson, Stride, TransAlta and Murphy USA
10:16am, Friday, 15'th Jul 2022 Zacks Investment Research
H&R Block, McKesson, Stride, TransAlta and Murphy USA are part of Zacks Value Trader blog.
